Understanding how specific proteins help manage cellular stress and protein aggregation
Mechanistic insight to the interaction between AAA+ disaggregases and the Hsp70 molecular chaperone system
This study is looking at how a protein called Hsp104 works with another protein system to help keep our cells healthy by breaking down harmful clumps of proteins that can cause diseases like Alzheimer's, and it aims to find ways to boost Hsp104's activity to help with these conditions.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10902929 on NIH RePORTER |
What this research studies
This research investigates the interaction between a protein called Hsp104 and the Hsp70 molecular chaperone system, which are crucial for maintaining protein health in cells. By using advanced imaging techniques, the study aims to uncover how these proteins work together to dissolve harmful protein aggregates that can lead to neurodegenerative diseases. The research focuses on understanding the mechanisms that enhance the activity of Hsp104, which is vital for cellular stress responses. This could provide insights into potential therapeutic strategies for conditions associated with protein misfolding.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for or diagnosed with neurodegenerative diseases linked to protein aggregation.
Not a fit: Patients with conditions unrelated to protein aggregation or cellular stress responses may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for neurodegenerative diseases by improving our understanding of protein aggregation and cellular stress responses.
How similar studies have performed: Previous research has shown promising results in understanding protein aggregation and chaperone systems, indicating that this approach has potential for significant breakthroughs.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Flores, Rachel L — University of California, San Francisco
- Study coordinator: Flores, Rachel L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.